COVID-19 vaccine data
This page is updated weekly at 1pm on Wednesday. Vaccine data is up to Sunday 3 May 2026.
About COVID-19 vaccine data
All data comes from the Aotearoa Immunisation Register (AIR).
- Metrics on this page can use 1 of 2 views of the data.
- Operational view — shows all doses administered in New Zealand.
Person view — shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand.
Those who have been vaccinated overseas will only appear in the person view. The person view includes all people that are currently alive and in AIR.
On 12 June 2024, the estimated population was changed to be sourced from AIR instead of the most recent Health Service User (HSU).
COVID-19 vaccinations summary
| Metric | Total |
| Second boosters administered | 1,143,475 |
| Total doses administered | 14,337,854 |
| First boosters administered | 2,791,808 |
| Percentage of 12 years and older who have completed primary course | 81.9% |
| Percentage of eligible 50 years and older who have received second booster | 57.2% |
| Percentage of eligible 18 years and older who have received first booster | 70.5% |
Total vaccinations
This table is an operational view.
Definitions
- Cumulative total
- All vaccinations that have been administered and entered into the AIR and including Sunday 3 May 2026.
- Vaccinations last week
- Over the 7 days up to and including Sunday 3 May 2026.
| Dose | Vaccinations last week | Cumulative total |
| Primary course doses (12 and older) | 273 | 8,030,291 |
| Booster 1 | 272 | 2,791,808 |
| Booster 2 | 1,625 | 1,143,475 |
| Booster 3+ | 20,071 | 1,939,307 |
| Paediatric first dose | 10 | 273,261 |
| Paediatric second dose | 6 | 159,116 |
| Infant first dose | 1 | 252 |
| Infant second dose | 0 | 156 |
| Infant third dose | 0 | 188 |
| Total doses | 22,258 | 14,337,854 |
Booster breakdowns
These tables are a person view.
Booster counts by ethnicity
| Ethnicity | Booster 1 (16 to 17) | Booster 1 (18 and older) | Booster 2 (50 and older) |
| Māori | 168 | 260,652 | 71,077 |
| Pacific Peoples | 66 | 155,339 | 30,665 |
| Asian | 184 | 471,608 | 70,898 |
| Other | 972 | 1,794,029 | 708,967 |
| Total | 1,390 | 2,681,628 | 881,607 |
Booster 2 uptake by age group
| Age group | Eligible | Received | Uptake |
| 30 to 34 | 197,810 | 40,847 | 20.6% |
| 35 to 49 | 646,887 | 144,235 | 22.3% |
| 50 to 64 | 718,670 | 287,938 | 40.1% |
| 65 and older | 823,385 | 593,669 | 72.1% |
Vaccine uptake percentage by age band
This bar graph shows current COVID-19 vaccination uptake by age band, with bars separated into 3 categories.
- Individuals fully vaccinated.
- Individuals partially vaccinated.
- Individuals unvaccinated.
This graph shows that:
- all of the older age groups from age group 45 to 49 and above have surpassed 90% of individuals being fully vaccinated
- for ages between 18 and 44, between 70% and 90 % of individuals are fully vaccinated
- for ages between 5 to 17 the fully vaccinated percentage is below 50%.
Vaccine uptake percentage by district of residence 12 years and older
This bar graph shows current COVID-19 vaccination uptake by district of residence for ages 12 and above, with bars separated into 3 categories.
- Individuals fully vaccinated.
- Individuals partially vaccinated.
- Individuals unvaccinated.
This graph shows that all districts have a relatively similar percentage of individuals fully vaccinated, all between 70% and 90%.
These figures do not include tamariki aged 0 to 11.
Vaccinations by week
This stacked column graph shows the number of COVID-19 vaccinations by week from the week ending 21 February 2021 until the most recent week ending Sunday.
This graph shows:
- the highest peak of vaccinations around August to October 2021
- a second large peak around January to February 2022.
During the first peak there were approximately 400,000 to 500,000 vaccinations each week. While during the second peak there were approximately 200,000 to 400,000 vaccinations each week.
After these 2 peaks the number of vaccinations remains significantly lower, with less than 100,000 vaccinations in any given week. This graph is also broken down with the colour of the stacks in each column representing the type of dose:
- primary course
- first booster
- second booster
- third booster +
- paediatric first
- paediatric second.
The first peak consisted of primary course doses while the second peak consisted mostly of first booster doses. From:
- June to December 2022 the vast majority of vaccinations were second boosters
- early 2023 most vaccinations are third boosters or higher.
Adverse events following immunisations (AEFI)
Like all medicines, the COVID-19 vaccine may cause side effects in some people. These side effects:
- are common
- are usually mild
- do not last long
- will not stop people from having the second dose or going about daily life.
Serious allergic reactions do happen but are extremely rare.
Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). While Medsafe no longer publishes their COVID-19 vaccine safety reports, they continue to monitor reports of adverse reactions submitted to CARM.
Centre for Adverse Reactions Monitoring (CARM) — University of Otagoexternal link





